Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CMLS Holdings III LLC is the sponsor of CM Life Sciences III Inc., a SPAC formed to enable public market entry for innovative life sciences companies; it successfully merged CM Life Sciences III Inc. with EQRx, Inc., a biopharma company, in a reverse merger valued at $4.2 billion.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CMLS Holdings.